Do analysts rate RVP or RMTI?

Rockwell Medical has a consensus price target of $20.00, suggesting a potential upside of 153.49%. Given Rockwell Medical's stronger consensus rating and higher possible upside, analysts clearly believe Rockwell Medical is more favorable than Retractable Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Retractable Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Rockwell Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts prefer CUPR or RMTI?

Rockwell Medical has a consensus target price of $20.00, indicating a potential upside of 153.49%. Given Rockwell Medical's stronger consensus rating and higher possible upside, analysts clearly believe Rockwell Medical is more favorable than Cuprina Holdings (Cayman). Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cuprina Holdings (Cayman) 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Rockwell Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has preferable valuation and earnings, CUPR or RMTI?

Cuprina Holdings (Cayman) has higher earnings, but lower revenue than Rockwell Medical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cuprina Holdings (Cayman) $40K 295.75 -$3.63M N/A N/A Rockwell Medical $69.26M 0.46 -$5.31M -$1.34 N/A

Do analysts prefer LUCY or RMTI?

Rockwell Medical has a consensus price target of $20.00, indicating a potential upside of 153.49%. Given Rockwell Medical's stronger consensus rating and higher probable upside, analysts plainly believe Rockwell Medical is more favorable than Innovative Eyewear. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Innovative Eyewear 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Rockwell Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media favor LUCY or RMTI?

In the previous week, Innovative Eyewear and Innovative Eyewear both had 5 articles in the media. Innovative Eyewear's average media sentiment score of 0.11 beat Rockwell Medical's score of -0.21 indicating that Innovative Eyewear is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Innovative Eyewear 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Rockwell Medical 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer BMRA or RMTI?

In the previous week, Rockwell Medical had 3 more articles in the media than Biomerica. MarketBeat recorded 5 mentions for Rockwell Medical and 2 mentions for Biomerica. Biomerica's average media sentiment score of 0.37 beat Rockwell Medical's score of -0.21 indicating that Biomerica is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Biomerica 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Rockwell Medical 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Rockwell Medical (RMTI) Competitors

$7.89 -0.13 (-1.62%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$8.14 +0.25 (+3.22%)

As of 10/9/2026 07:56 PM Eastern

Compare

RMTI vs. NEPH, RVP, CUPR, LUCY, and BMRA

Should you buy Rockwell Medical stock or one of its competitors? Rockwell Medical's main competitors and comparable companies include Nephros (NEPH), Retractable Technologies (RVP), Cuprina Holdings (Cayman) (CUPR), Innovative Eyewear (LUCY), and Biomerica (BMRA). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does Rockwell Medical compare to Nephros?

Nephros (NASDAQ:NEPH) and Rockwell Medical (NASDAQ:RMTI) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, risk, valuation, profitability, media sentiment, institutional ownership and dividends.

Nephros currently has a consensus price target of $4.00, indicating a potential upside of 13.31%. Rockwell Medical has a consensus price target of $20.00, indicating a potential upside of 153.49%. Given Rockwell Medical's higher probable upside, analysts plainly believe Rockwell Medical is more favorable than Nephros.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nephros	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.25
Rockwell Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

41.1% of Nephros shares are owned by institutional investors. Comparatively, 23.3% of Rockwell Medical shares are owned by institutional investors. 6.7% of Nephros shares are owned by company insiders. Comparatively, 4.6% of Rockwell Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Rockwell Medical had 3 more articles in the media than Nephros. MarketBeat recorded 5 mentions for Rockwell Medical and 2 mentions for Nephros. Nephros' average media sentiment score of 0.00 beat Rockwell Medical's score of -0.21 indicating that Nephros is being referred to more favorably in the media.

Company	Overall Sentiment
Nephros	Neutral
Rockwell Medical	Neutral

Nephros has a net margin of 8.38% compared to Rockwell Medical's net margin of -7.33%. Nephros' return on equity of 10.60% beat Rockwell Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nephros	8.38%	10.60%	8.05%
Rockwell Medical	-7.33%	-14.03%	-8.90%

Nephros has higher earnings, but lower revenue than Rockwell Medical. Rockwell Medical is trading at a lower price-to-earnings ratio than Nephros, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nephros	$18.79M	2.04	$1.19M	$0.16	22.06
Rockwell Medical	$69.26M	0.46	-$5.31M	-$1.34	N/A

Nephros has a beta of 1.64, meaning that its stock price is 64% more volatile than the broader market. Comparatively, Rockwell Medical has a beta of 1.63, meaning that its stock price is 63% more volatile than the broader market.

Summary

Nephros beats Rockwell Medical on 12 of the 15 factors compared between the two stocks.

How does Rockwell Medical compare to Retractable Technologies?

Retractable Technologies (NYSE:RVP) and Rockwell Medical (NASDAQ:RMTI) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, media sentiment, analyst recommendations, profitability, institutional ownership and risk.

In the previous week, Rockwell Medical had 5 more articles in the media than Retractable Technologies. MarketBeat recorded 5 mentions for Rockwell Medical and 0 mentions for Retractable Technologies. Retractable Technologies' average media sentiment score of 0.00 beat Rockwell Medical's score of -0.21 indicating that Retractable Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
Retractable Technologies	Neutral
Rockwell Medical	Neutral

Rockwell Medical has a net margin of -7.33% compared to Retractable Technologies' net margin of -41.11%. Rockwell Medical's return on equity of -14.03% beat Retractable Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Retractable Technologies	-41.11%	-17.15%	-9.33%
Rockwell Medical	-7.33%	-14.03%	-8.90%

Retractable Technologies has a beta of 1.2, suggesting that its stock price is 20% more volatile than the broader market. Comparatively, Rockwell Medical has a beta of 1.63, suggesting that its stock price is 63% more volatile than the broader market.

Rockwell Medical has a consensus price target of $20.00, suggesting a potential upside of 153.49%. Given Rockwell Medical's stronger consensus rating and higher possible upside, analysts clearly believe Rockwell Medical is more favorable than Retractable Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Rockwell Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

7.6% of Retractable Technologies shares are owned by institutional investors. Comparatively, 23.3% of Rockwell Medical shares are owned by institutional investors. 59.5% of Retractable Technologies shares are owned by insiders. Comparatively, 4.6% of Rockwell Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Rockwell Medical has higher revenue and earnings than Retractable Technologies. Rockwell Medical is trading at a lower price-to-earnings ratio than Retractable Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Retractable Technologies	$33.90M	0.59	-$7.01M	-$0.12	N/A
Rockwell Medical	$69.26M	0.46	-$5.31M	-$1.34	N/A

Summary

Rockwell Medical beats Retractable Technologies on 11 of the 16 factors compared between the two stocks.

How does Rockwell Medical compare to Cuprina Holdings (Cayman)?

Cuprina Holdings (Cayman) (NASDAQ:CUPR) and Rockwell Medical (NASDAQ:RMTI) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, risk, earnings, valuation, institutional ownership and media sentiment.

Cuprina Holdings (Cayman) has higher earnings, but lower revenue than Rockwell Medical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cuprina Holdings (Cayman)	$40K	295.75	-$3.63M	N/A	N/A
Rockwell Medical	$69.26M	0.46	-$5.31M	-$1.34	N/A

Rockwell Medical has a consensus target price of $20.00, indicating a potential upside of 153.49%. Given Rockwell Medical's stronger consensus rating and higher possible upside, analysts clearly believe Rockwell Medical is more favorable than Cuprina Holdings (Cayman).

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cuprina Holdings (Cayman)	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Rockwell Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Rockwell Medical had 4 more articles in the media than Cuprina Holdings (Cayman). MarketBeat recorded 5 mentions for Rockwell Medical and 1 mentions for Cuprina Holdings (Cayman). Cuprina Holdings (Cayman)'s average media sentiment score of 0.00 beat Rockwell Medical's score of -0.21 indicating that Cuprina Holdings (Cayman) is being referred to more favorably in the media.

Company	Overall Sentiment
Cuprina Holdings (Cayman)	Neutral
Rockwell Medical	Neutral

Cuprina Holdings (Cayman) has a beta of -0.1, suggesting that its stock price is 110% less volatile than the broader market. Comparatively, Rockwell Medical has a beta of 1.63, suggesting that its stock price is 63% more volatile than the broader market.

Cuprina Holdings (Cayman) has a net margin of 0.00% compared to Rockwell Medical's net margin of -7.33%. Cuprina Holdings (Cayman)'s return on equity of 0.00% beat Rockwell Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cuprina Holdings (Cayman)	N/A	N/A	N/A
Rockwell Medical	-7.33%	-14.03%	-8.90%

23.3% of Rockwell Medical shares are held by institutional investors. 4.6% of Rockwell Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Rockwell Medical beats Cuprina Holdings (Cayman) on 8 of the 14 factors compared between the two stocks.

How does Rockwell Medical compare to Innovative Eyewear?

Innovative Eyewear (NASDAQ:LUCY) and Rockwell Medical (NASDAQ:RMTI) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, valuation, media sentiment, profitability, risk, dividends, earnings and institutional ownership.

Rockwell Medical has a consensus price target of $20.00, indicating a potential upside of 153.49%. Given Rockwell Medical's stronger consensus rating and higher probable upside, analysts plainly believe Rockwell Medical is more favorable than Innovative Eyewear.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Innovative Eyewear	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Rockwell Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Innovative Eyewear has a beta of 2.74, suggesting that its stock price is 174% more volatile than the broader market. Comparatively, Rockwell Medical has a beta of 1.63, suggesting that its stock price is 63% more volatile than the broader market.

In the previous week, Innovative Eyewear and Innovative Eyewear both had 5 articles in the media. Innovative Eyewear's average media sentiment score of 0.11 beat Rockwell Medical's score of -0.21 indicating that Innovative Eyewear is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Innovative Eyewear	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Rockwell Medical	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Rockwell Medical has higher revenue and earnings than Innovative Eyewear. Rockwell Medical is trading at a lower price-to-earnings ratio than Innovative Eyewear, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Innovative Eyewear	$3.41M	2.31	-$7.59M	-$1.29	N/A
Rockwell Medical	$69.26M	0.46	-$5.31M	-$1.34	N/A

Rockwell Medical has a net margin of -7.33% compared to Innovative Eyewear's net margin of -225.26%. Rockwell Medical's return on equity of -14.03% beat Innovative Eyewear's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Innovative Eyewear	-225.26%	-88.90%	-80.34%
Rockwell Medical	-7.33%	-14.03%	-8.90%

1.0% of Innovative Eyewear shares are owned by institutional investors. Comparatively, 23.3% of Rockwell Medical shares are owned by institutional investors. 1.7% of Innovative Eyewear shares are owned by company insiders. Comparatively, 4.6% of Rockwell Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Rockwell Medical beats Innovative Eyewear on 10 of the 15 factors compared between the two stocks.

How does Rockwell Medical compare to Biomerica?

Biomerica (NASDAQ:BMRA) and Rockwell Medical (NASDAQ:RMTI) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, media sentiment, analyst recommendations, earnings and valuation.

In the previous week, Rockwell Medical had 3 more articles in the media than Biomerica. MarketBeat recorded 5 mentions for Rockwell Medical and 2 mentions for Biomerica. Biomerica's average media sentiment score of 0.37 beat Rockwell Medical's score of -0.21 indicating that Biomerica is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Biomerica	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Rockwell Medical	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Biomerica has higher earnings, but lower revenue than Rockwell Medical. Rockwell Medical is trading at a lower price-to-earnings ratio than Biomerica, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biomerica	$4.45M	1.27	-$3.78M	-$1.27	N/A
Rockwell Medical	$69.26M	0.46	-$5.31M	-$1.34	N/A

Rockwell Medical has a net margin of -7.33% compared to Biomerica's net margin of -84.79%. Rockwell Medical's return on equity of -14.03% beat Biomerica's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biomerica	-84.79%	-97.19%	-61.57%
Rockwell Medical	-7.33%	-14.03%	-8.90%

Biomerica has a beta of 0.38, meaning that its stock price is 62% less volatile than the broader market. Comparatively, Rockwell Medical has a beta of 1.63, meaning that its stock price is 63% more volatile than the broader market.

Biomerica presently has a consensus price target of $9.00, indicating a potential upside of 391.80%. Rockwell Medical has a consensus price target of $20.00, indicating a potential upside of 153.49%. Given Biomerica's higher probable upside, equities analysts plainly believe Biomerica is more favorable than Rockwell Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biomerica	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Rockwell Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

22.3% of Biomerica shares are owned by institutional investors. Comparatively, 23.3% of Rockwell Medical shares are owned by institutional investors. 18.0% of Biomerica shares are owned by insiders. Comparatively, 4.6% of Rockwell Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Rockwell Medical beats Biomerica on 9 of the 16 factors compared between the two stocks.

Get Rockwell Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RMTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RMTI vs. The Competition

Export

Metric	Rockwell Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$32.33M	$5.43B	$7.16B	$13.21B
Dividend Yield	N/A	1.77%	2.53%	16.37%
P/E Ratio	-5.89	25.57	275.30	26.16
Price / Sales	0.46	83.34	635.97	107.53
Price / Cash	N/A	31.87	76.38	53.09
Price / Book	0.84	5.95	11.22	6.33
Net Income	-$5.31M	$146.18M	$3.50B	$382.15M
7 Day Performance	-8.79%	-0.28%	-0.89%	-1.40%
1 Month Performance	-1.87%	-1.88%	-4.42%	-3.47%
1 Year Performance	-28.27%	5.45%	7.03%	1.18%

Rockwell Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RMTI Rockwell Medical	3.3416 of 5 stars	$7.89 -1.6%	$20.00 +153.5%	-34.8%	$32.33M	$69.39M	N/A	157	News Coverage Analyst Upgrade
NEPH Nephros	4.3545 of 5 stars	$3.63 +2.1%	$4.00 +10.3%	-34.6%	$39.37M	$20.72M	22.66	36	Short Interest Decrease
RVP Retractable Technologies	N/A	$0.70 +1.0%	N/A	-35.5%	$21.02M	$33.90M	N/A	201
CUPR Cuprina Holdings (Cayman)	0.7643 of 5 stars	$2.14 -5.1%	N/A	N/A	$14.95M	$49.89K	N/A	10	Gap Down
LUCY Innovative Eyewear	0.6442 of 5 stars	$0.93 +3.9%	N/A	-54.4%	$8.06M	$2.66M	N/A	13	News Coverage Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RMTI) was last updated on 10/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rockwell Medical (RMTI) Competitors

RMTI vs. NEPH, RVP, CUPR, LUCY, and BMRA

How does Rockwell Medical compare to Nephros?

Summary

How does Rockwell Medical compare to Retractable Technologies?

Summary

How does Rockwell Medical compare to Cuprina Holdings (Cayman)?

Summary

How does Rockwell Medical compare to Innovative Eyewear?

Summary

How does Rockwell Medical compare to Biomerica?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RMTI vs. The Competition

Rockwell Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Rockwell Medical (RMTI) Competitors

RMTI vs. NEPH, RVP, CUPR, LUCY, and BMRA

How does Rockwell Medical compare to Nephros?

Do analysts rate NEPH or RMTI?

Do institutionals & insiders have more ownership in NEPH or RMTI?

Does the media favor NEPH or RMTI?

Is NEPH or RMTI more profitable?

Which has better earnings and valuation, NEPH or RMTI?

Which has more risk and volatility, NEPH or RMTI?

Summary

How does Rockwell Medical compare to Retractable Technologies?

Does the media prefer RVP or RMTI?

Is RVP or RMTI more profitable?

Which has more volatility & risk, RVP or RMTI?

Do analysts rate RVP or RMTI?

Do institutionals and insiders hold more shares of RVP or RMTI?

Which has better valuation & earnings, RVP or RMTI?

Summary

How does Rockwell Medical compare to Cuprina Holdings (Cayman)?

Which has preferable valuation and earnings, CUPR or RMTI?

Do analysts prefer CUPR or RMTI?

Does the media favor CUPR or RMTI?

Which has more volatility & risk, CUPR or RMTI?

Is CUPR or RMTI more profitable?

Do institutionals & insiders have more ownership in CUPR or RMTI?

Summary

How does Rockwell Medical compare to Innovative Eyewear?

Do analysts prefer LUCY or RMTI?

Which has more risk and volatility, LUCY or RMTI?

Does the media favor LUCY or RMTI?

Which has stronger valuation & earnings, LUCY or RMTI?

Is LUCY or RMTI more profitable?

Do institutionals and insiders have more ownership in LUCY or RMTI?

Summary

How does Rockwell Medical compare to Biomerica?

Does the media prefer BMRA or RMTI?

Which has stronger valuation & earnings, BMRA or RMTI?

Is BMRA or RMTI more profitable?

Which has more risk & volatility, BMRA or RMTI?

Do analysts prefer BMRA or RMTI?

Do institutionals & insiders believe in BMRA or RMTI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RMTI vs. The Competition

Rockwell Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools